OpenAI acquires startup Orchestra Bio to beef up its biotech business
OpenAI says it's adding Orchestra's team and technology to work on Rosalind, its AI model for life sciences research, and to its related Rosalind Workbench tool, a harness that aims to help researchers plan experiments and analyze results.
Covered in this story
Dalsna Finance is currently tracking 11 stories mentioning OpenAI, the earliest published 17 Aug 2026.
Summary aggregated from TechCrunch's public RSS feed. The full reporting belongs to TechCrunch — please read it on their site.